Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies

被引：0
|
作者：
Jinqi Huang
Stepanov Alexey
Jian Li
Terri Jones
Geramie Grande
Lacey Douthit
Jun Xie
Danna Chen
Xiaolei Wu
Maschan Michael
Changchun Xiao
Jiangning Zhao
Xuehua Xie
Jia Xie
Xiao Lei Chen
Guo Fu
Gabibov Alexander
Chi-Meng Tzeng
机构：
[1] Xiamen University,Translational Medicine Research Center (TMRC), School of Pharmaceutical Sciences
[2] The Scripps Research Institute,Department of Chemistry
[3] Russian Academy of Sciences,M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry
[4] Xiamen University,State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences
[5] The Affiliated Hospital of Putian University,Department of Immunology and Microbiology
[6] ProteinT Biotechnology Ltd. Co. Tianjin Airport Free Trade Zone,Department of Hematology
[7] Dmitrii Rogachev Federal Research Center for Pediatric Hematology,Department of Oncology
[8] Oncology and Immunology,School of Pharmacology
[9] The Scripps Research Institute,undefined
[10] zhongshan Hospital of Xiamen University,undefined
[11] The first hospital of Putian City,undefined
[12] Nanjing Tech University,undefined
来源：
Leukemia | 2019年 / 33卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2315 / 2319
页数：4
相关论文
共 50 条
  • [1] Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies
    Huang, Jinqi
    Alexey, Stepanov
    Li, Jian
    Jones, Terri
    Grande, Geramie
    Douthit, Lacey
    Xie, Jun
    Chen, Danna
    Wu, Xiaolei
    Michael, Maschan
    Xiao, Changchun
    Zhao, Jiangning
    Xie, Xuehua
    Xie, Jia
    Chen, Xiao Lei
    Fu, Guo
    Alexander, Gabibov
    Tzeng, Chi-Meng
    LEUKEMIA, 2019, 33 (09) : 2315 - 2319
  • [2] Correction: Unique CDR3 epitope targeting by CAR-T cells is a viable approach for treating T-cell malignancies
    Jinqi Huang
    Stepanov Alexey
    Jian Li
    Terri Jones
    Geramie Grande
    Lacey Douthit
    Jun Xie
    Danna Chen
    Xiaolei Wu
    Maschan Michael
    Changchun Xiao
    Jiangning Zhao
    Xuehua Xie
    Jia Xie
    Xiao Lei Chen
    Guo Fu
    Gabibov Alexander
    Chi-Meng Tzeng
    Leukemia, 2019, 33 : 2341 - 2341
  • [3] CAR-T Cell Therapy for T-Cell Malignancies
    Testa, Ugo
    Chiusolo, Patrizia
    Pelosi, Elvira
    Castelli, Germana
    Leone, Giuseppe
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [4] Targeting T cell malignancies with gene edited CAR-T
    Dipersio, John F.
    Cooper, Matthew
    CANCER RESEARCH, 2018, 78 (13)
  • [5] Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies
    Cooper, Mathew L.
    DiPersio, John F.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2019, 32 (04)
  • [6] Current state of CAR-T therapy for T-cell malignancies
    Luo, Liangkui
    Zhou, Xuan
    Zhou, Lijuan
    Liang, Zhao
    Yang, Jilong
    Tu, Sanfang
    Li, Yuhua
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [7] Current state of CAR-T therapy for T-cell malignancies
    Luo, Liangkui
    Zhou, Xuan
    Zhou, Lijuan
    Liang, Zhao
    Yang, Jilong
    Tu, Sanfang
    Li, Yuhua
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [8] Safe CAR-T: shedding light on CAR-related T-cell malignancies
    Liao, Qibin
    Xu, Jianqing
    EMBO MOLECULAR MEDICINE, 2025, : 589 - 593
  • [9] PRESENTATION OF A VIRAL T-CELL EPITOPE EXPRESSED IN THE CDR3 REGION OF A SELF IMMUNOGLOBULIN MOLECULE
    ZAGHOUANI, H
    STEINMAN, R
    NONACS, R
    SHAH, H
    GERHARD, W
    BONA, C
    SCIENCE, 1993, 259 (5092) : 224 - 227
  • [10] CAR-T for the treatment of T cell malignancies
    DiPersio, John F.
    MEDICINE, 2019, 98 (26)
12345